Spruce Biosciences, Inc. Common Stock Financial Flexibility Index
Spruce Biosciences, Inc. Common Stock financial flexibility index. Spruce Biosciences, Inc. Common Stock (SPRB) has a Financial Flexibility Index of -1.15x as of June 2026. Free cash flow of $-21.98 Million (operating CF $-22.12 Million minus capex $135.00K) represents -1% of total liabilities ($19.12 Million). See Spruce Biosciences, Inc. Common Stock free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Spruce Biosciences, Inc. Common Stock (2018–2025)
Financial flexibility index of Spruce Biosciences, Inc. Common Stock from 2018 to 2025. Historical Financial Flexibility Index trend for Spruce Biosciences, Inc. Common Stock across 8 annual periods. Explore debt repayment capacity of Spruce Biosciences, Inc. Common Stock to assess how comfortably operating cash covers total debt obligations.
Spruce Biosciences, Inc. Common Stock Financial Flexibility Index by Year (2018–2025)
Spruce Biosciences, Inc. Common Stock financial flexibility index by year from 2018 to 2025. Year-by-year free cash flow to debt coverage for Spruce Biosciences, Inc. Common Stock. For the full cash flow conversion analysis, see cash efficiency ratio of Spruce Biosciences, Inc. Common Stock.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -3.17x | $-33.33 Million | $-33.33 Million | $10.51 Million | ▲ +7.1% |
| 2024 | -3.41x | $-55.96 Million | $-55.96 Million | $16.39 Million | ▼ -181.6% |
| 2023 | -1.21x | $-33.27 Million | $-33.27 Million | $27.44 Million | ▲ +50.1% |
| 2022 | -2.43x | $-41.67 Million | $-41.68 Million | $17.16 Million | ▼ -2.6% |
| 2021 | -2.37x | $-35.78 Million | $-35.88 Million | $15.12 Million | ▼ -16.1% |
| 2020 | -2.04x | $-27.45 Million | $-27.52 Million | $13.46 Million | ▼ -471.3% |
| 2019 | -0.36x | $-12.61 Million | $-12.62 Million | $35.33 Million | ▲ +5.9% |
| 2018 | -0.38x | $-8.57 Million | $-8.57 Million | $22.58 Million | — |